化工社化工社 化学情報印刷レポート · 研究参考用
HRID 856250作成日:2026年10月25日
Dimethylformamide → 2-Methyl-6-nitro-2-[4-(4-trifluoromethylbenzoyl)piperidin-1-yl]methyl-2,3-dihydroimidazo[2,1-b]oxazole
https://huagongshe.com/reaction/856250
関与物質
| 役割 | 名称 | HCID | 仕込み量 |
|---|
| 反応物 | Dimethylformamide | HCID 6228 | — |
| 反応物 | Sodium Acetate | HCID 517045 | — |
| 反応物 | 4-(4-Trifluoromethylbenzoyl)piperidine | HCID 11637455 | — |
| 反応物 | 2-Chloro-1-(2-methyloxiran-2-ylmethyl)-4-nitroimidazole | HCID 15965523 | — |
| 溶媒 | Water | HCID 962 | — |
| 生成物 | 2-Methyl-6-nitro-2-[4-(4-trifluoromethylbenzoyl)piperidin-1-yl]methyl-2,3-dihydroimidazo[2,1-b]oxazole | HCID 69483093 | 29% |
反応手順
A mixture of 2-chloro-1-(2-methyloxiran-2-ylmethyl)-4-nitroimidazole prepared in Example 6 (80 mg, 0.37 mmol), 4-(4-trifluoromethylbenzoyl)piperidine (95 mg, 0.37 mmol), sodium acetate (150 mg, 1.83 mmol) and DMF (2 ml) was stirred at 80° C. overnight. The reaction mixture was poured into water, and extracted with ethyl acetate twice. The organic phases were combined, washed with water three times, washed with a saturated saline solution, dried over sodium sulfate and then concentrated under reduced pressure. The residue was purified by silica gel column chromatography (ethyl acetate/n-hexane=1/1) to afford 2-methyl-6-nitro-2-[4-(4-trifluoromethylbenzoyl)piperidin-1-yl]methyl-2,3-dihydroimidazo[2,1-b]oxazole (46 mg, yield 29%) as a white powder.
情報源と証拠
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 特許番号 | US07262212B2 |
|---|
| 出典データセット | uspto-grants-2007_08 |
|---|
| ORD ID | ord-20cf7a1eeea74674948a0059cc2514ee |
|---|
| 出典メモ | uspto-grants-2007_08 |
|---|